William Daniel Follas, President and CEO of Xeno, has extensive experience in the laboratory and medical industry. Dan and his brother Evan founded Follas Laboratories in 1979. Starting from the ground up, Dan grew Follas Laboratories into a successful organization serving many medical groups and hospitals in Indiana while employing over 60 people. During this time, Dan focused on finding ways to develop newfound advances in technology and information into practical solutions for patient healthcare. Seeing a need for improved fertility services in Indiana, Dan developed laboratory testing and programs to address this need. Currently he has been involved with the creation of two fertility clinics, the Follas Center for Reproductive Medicine, LLC., and the Advanced Reproduction Institute, LLC. Dan continues to strive for the general improvement of healthcare with his vision, to better understand and address the inflammatory process of disease through Xeno diagnostics.
Neil Balgobin, Ph.D. is a senior scientist with extensive experience in Diagnostics, Life Sciences, and Biotech Industries. Neil has intimate knowledge and familiarity with the commercialization of new products as he has been involved in all stages of development, from technology evaluation through research, scale up and launch, as well as process improvements contributing to company profits. Beyond the evaluation and introduction of new technology platforms, Neil also has experience in project management, and product development, from discovery through GMP production. More specifically, Dr. Balgobin has validated and introduced new assays and platforms for Immunoassay and Molecular Diagnostics while maintaining laboratory compliance with the accrediting organizations CAP and CLIA. His work also includes the establishment and implementation of new QC test procedures, and the creation of all GMP manufacturing documents necessary for new products. Neil’s experience is well suited to accomplish Xeno Diagnostic’s goals of creating new testing services and products.
Dr. Moazzam Khan received his PhD in Biochemistry from Aligarh University in India in 1970. Dr. Khan then came to the United States and began work as a Research Associate at the Indiana University Medical Center. Dr. Khan also spent time as a Research Associate at Mount Sinai Hospital in New York. His research was published in multiple peer-reviewed journals. Dr. Khan went on to hold various teaching and managerial positions in Hospitals and Universities in New York, Pennsylvania, and Indiana.
Dr. Khan joined Follas Laboratories as the Laboratory Director in 1988. Dr. Khan structured and managed the daily Quality Control, calibration, and verification of the laboratory’s instrumentation in the areas of Chemistry, Special Chemistry, Enzyme Immunoassays (EIA), Radio-immunoassays (RIA), Coagulation, Hematology, and Urinalysis. After merging operations with another area lab, Dr. Khan became the Technical Coordinator & Director. His responsibilities included directing the technical operations of the aforementioned areas of the lab, developing and evaluating new lab tests, evaluating and selecting biomedical equipment, reviewing departmental policies and procedures, monitoring employee performance, and maintaining the laboratory’s Quality Assurance and Quality Control programs to maintain compliance with CLIA regulations.
Currently, Dr. Khan acts as a consultant to other independent clinical laboratories, and teaches bioethics at a local college. Dr. Khan’s expertise is a valuable asset to clients providing services in medical laboratories working under the regulatory guidelines of CLIA ’88.